POET Technologies forecasts a $25 share price by 2027, nearly triple current levels, contingent on facility ramp and order conversion.
POET Technologies projects its shares could reach $25 by 2027, up from $8.33, driven by its Malaysia 800G facility ramp and Lumilens converting a $50M initial order into recurring revenue. The internal base case targets $22.23, nearly double the lone analyst consensus of $17.50.
Despite 202% year-over-year revenue growth in Q1 2026, POET shares have fallen 38.52% over the past month. Legal challenges, including class action lawsuits over PFIC status and a CFO-related confidentiality breach, alongside a $400 million dilutive offering and CEO exit on July 8, 2026, have weighed on sentiment.
Shares remain under pressure, down 6.63% in the past week, as investors digest the impact of recent setbacks on long-term growth projections.